Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
45 Results Found
CDC: Studies reinforce effectiveness of mpox vaccination for people at risk
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with the JYNNEOS vaccine as recommended, the Centers for Disease Control and Prevention advised, pointing to three new studies supporting the vaccine’s effectiveness against the virus.
FDA authorizes new monkeypox point-of-care test, updates COVID-19 medical device shortages
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in lesion swab specimens from individuals whose health care provider suspects they have the virus.
FDA authorizes monkeypox test, issues update on recalled ventilators
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as monkeypox) in lesion swab specimens from individuals whose health care provider suspects they have the virus
CDC: Vaccine found safe, effective against mpox during outbreak
In a study of men under age 50 who were eligible to receive the JYNNEOS vaccine to prevent monkeypox (mpox) during the U.S. outbreak this year, unvaccinated men were 10 times more likely to get the virus than men who received the two-dose vaccine, and seven times more likely to get it than men who received only one vaccine dose.
WHO recommends new name for monkeypox
The World Health Organization today recommended a new name for monkeypox that is intended to mitigate a rise in related racist and stigmatizing language associated with the ailment. The WHO’s newly recommended preferred term is “mpox.”
HHS renews monkeypox public health emergency for 90 days
The Department of Health and Human Services today renewed the nation’s monkeypox public health emergency declaration for another 90 days. When the PHE was announced in August, Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., said the declaration would provide access to resources and flexibilities, expedite state data sharing, and provide more detailed data on testing and hospitalizations.
CDC report highlights potential for severe monkeypox in untreated HIV patients
As the monkeypox outbreak slows in the U.S., a new report from the Centers for Disease Control and Prevention highlights devastating outcomes of monkeypox for people with severely weakened immune systems, particularly those with untreated HIV. The report examines 57 patients hospitalized with severe monkeypox since early August, including 12 who died.
CDC reports first U.S. monkeypox case in health care worker
The Centers for Disease Control and Prevention today reported the first U.S. monkeypox case in a health care worker since the outbreak began in May. The report describes how an emergency department nurse in Florida was exposed to the virus through a needlestick, and recommends approaches to preventing infections in health care workers.
FDA authorizes first commercial monkeypox test, pertussis vaccine for young infants
The FDA authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens.
HHS extends monkeypox emergency declaration, expands covered providers
Health and Human Services Secretary Xavier Becerra last week extended for 10 years his Aug. 4 public health emergency for monkeypox under the Public Readiness and Emergency Preparedness Act, and authorized additional providers to administer vaccines and therapeutics under the emergency declaration. The original declaration was effective through Dec. 31.